Loading…

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease

Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.

Saved in:
Bibliographic Details
Published in:International journal of chronic obstructive pulmonary disease 2021-01, Vol.16, p.495-498
Main Authors: Talman, Sander, Uzun, Sevim, Djamin, Remco S, Baart, Sara J, Grootenboers, Marco J J H, Aerts, Joachim, van der Eerden, Menno
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123
cites cdi_FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123
container_end_page 498
container_issue
container_start_page 495
container_title International journal of chronic obstructive pulmonary disease
container_volume 16
creator Talman, Sander
Uzun, Sevim
Djamin, Remco S
Baart, Sara J
Grootenboers, Marco J J H
Aerts, Joachim
van der Eerden, Menno
description Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.
doi_str_mv 10.2147/COPD.S284397
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_adab09f7e71d43ea9dc613ef50b3f6d8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A654649230</galeid><doaj_id>oai_doaj_org_article_adab09f7e71d43ea9dc613ef50b3f6d8</doaj_id><sourcerecordid>A654649230</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123</originalsourceid><addsrcrecordid>eNptkktvEzEQgFcIREvhxhmthIQ4kODXvi5IUdpCpaBEIpytWe84cbVrt_ZuoUj8d7xNqBKEfPDI8_mzPZ4keU3JlFFRfJwvV-fTb6wUvCqeJKeUFuWEEZI9PYhPkhchXMcgLwr6PDnhPC9LWmSnye-Fs5vJGn2Xzn6Zfutdd6-MTb-CsT1asArTtUfoO7R9GhMr6E0MQ_oj0umlx9thzFz8BIW-jklnQ-p0Oo8qa1S6rEPvB9WbO0xXQ9s5C_4-PTcBIeDL5JmGNuCr_XyWfL-8WM-_TBbLz1fz2WKisiLvJ9CosgKi64pwldcoKCsyIUpBAOuGKp0BJURQwaDKKYdGo64oA5KjaGrK-FlytfM2Dq7ljTddvIR0YOTDgvMbCb43qkUJDdSk0gUWtBEcoWpUVKLOSM113pTR9WnnuhnqDhsVX--hPZIeZ6zZyo27k0XFM85Gwfu9wLtYvNDLzgSFbQsW3RAkE1UVUSpG9O0_6LUbvI2lkiyPvpIRekBtID7AWO3iuWqUylmeiVxUjJNITf9DxdFgZ5SzqE1cP9rw7mDDFqHtt8G1w8MXH4MfdqDyLgSP-rEYlMixR-XYo3LfoxF_c1jAR_hvU_I_TG_ivg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2679382018</pqid></control><display><type>article</type><title>Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Talman, Sander ; Uzun, Sevim ; Djamin, Remco S ; Baart, Sara J ; Grootenboers, Marco J J H ; Aerts, Joachim ; van der Eerden, Menno</creator><creatorcontrib>Talman, Sander ; Uzun, Sevim ; Djamin, Remco S ; Baart, Sara J ; Grootenboers, Marco J J H ; Aerts, Joachim ; van der Eerden, Menno</creatorcontrib><description>Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.</description><identifier>ISSN: 1178-2005</identifier><identifier>ISSN: 1176-9106</identifier><identifier>EISSN: 1178-2005</identifier><identifier>DOI: 10.2147/COPD.S284397</identifier><identifier>PMID: 33688175</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Antibiotics ; Azithromycin ; Care and treatment ; Chronic obstructive pulmonary disease ; copd ; Cystic fibrosis ; exacerbations ; Hospitals ; Lung diseases, Obstructive ; macrolide ; maintenance-therapy ; Methicillin ; Patient admissions ; Pulmonology ; Quality of life ; Short Report ; Streptococcus infections</subject><ispartof>International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.495-498</ispartof><rights>2021 Talman et al.</rights><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><rights>2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Talman et al. 2021 Talman et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123</citedby><cites>FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123</cites><orcidid>0000-0002-7211-8839</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2679382018/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2679382018?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33688175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Talman, Sander</creatorcontrib><creatorcontrib>Uzun, Sevim</creatorcontrib><creatorcontrib>Djamin, Remco S</creatorcontrib><creatorcontrib>Baart, Sara J</creatorcontrib><creatorcontrib>Grootenboers, Marco J J H</creatorcontrib><creatorcontrib>Aerts, Joachim</creatorcontrib><creatorcontrib>van der Eerden, Menno</creatorcontrib><title>Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease</title><title>International journal of chronic obstructive pulmonary disease</title><addtitle>Int J Chron Obstruct Pulmon Dis</addtitle><description>Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.</description><subject>Antibiotics</subject><subject>Azithromycin</subject><subject>Care and treatment</subject><subject>Chronic obstructive pulmonary disease</subject><subject>copd</subject><subject>Cystic fibrosis</subject><subject>exacerbations</subject><subject>Hospitals</subject><subject>Lung diseases, Obstructive</subject><subject>macrolide</subject><subject>maintenance-therapy</subject><subject>Methicillin</subject><subject>Patient admissions</subject><subject>Pulmonology</subject><subject>Quality of life</subject><subject>Short Report</subject><subject>Streptococcus infections</subject><issn>1178-2005</issn><issn>1176-9106</issn><issn>1178-2005</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkktvEzEQgFcIREvhxhmthIQ4kODXvi5IUdpCpaBEIpytWe84cbVrt_ZuoUj8d7xNqBKEfPDI8_mzPZ4keU3JlFFRfJwvV-fTb6wUvCqeJKeUFuWEEZI9PYhPkhchXMcgLwr6PDnhPC9LWmSnye-Fs5vJGn2Xzn6Zfutdd6-MTb-CsT1asArTtUfoO7R9GhMr6E0MQ_oj0umlx9thzFz8BIW-jklnQ-p0Oo8qa1S6rEPvB9WbO0xXQ9s5C_4-PTcBIeDL5JmGNuCr_XyWfL-8WM-_TBbLz1fz2WKisiLvJ9CosgKi64pwldcoKCsyIUpBAOuGKp0BJURQwaDKKYdGo64oA5KjaGrK-FlytfM2Dq7ljTddvIR0YOTDgvMbCb43qkUJDdSk0gUWtBEcoWpUVKLOSM113pTR9WnnuhnqDhsVX--hPZIeZ6zZyo27k0XFM85Gwfu9wLtYvNDLzgSFbQsW3RAkE1UVUSpG9O0_6LUbvI2lkiyPvpIRekBtID7AWO3iuWqUylmeiVxUjJNITf9DxdFgZ5SzqE1cP9rw7mDDFqHtt8G1w8MXH4MfdqDyLgSP-rEYlMixR-XYo3LfoxF_c1jAR_hvU_I_TG_ivg</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Talman, Sander</creator><creator>Uzun, Sevim</creator><creator>Djamin, Remco S</creator><creator>Baart, Sara J</creator><creator>Grootenboers, Marco J J H</creator><creator>Aerts, Joachim</creator><creator>van der Eerden, Menno</creator><general>Dove Medical Press Limited</general><general>Dove Medical Press Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7211-8839</orcidid></search><sort><creationdate>20210101</creationdate><title>Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease</title><author>Talman, Sander ; Uzun, Sevim ; Djamin, Remco S ; Baart, Sara J ; Grootenboers, Marco J J H ; Aerts, Joachim ; van der Eerden, Menno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Azithromycin</topic><topic>Care and treatment</topic><topic>Chronic obstructive pulmonary disease</topic><topic>copd</topic><topic>Cystic fibrosis</topic><topic>exacerbations</topic><topic>Hospitals</topic><topic>Lung diseases, Obstructive</topic><topic>macrolide</topic><topic>maintenance-therapy</topic><topic>Methicillin</topic><topic>Patient admissions</topic><topic>Pulmonology</topic><topic>Quality of life</topic><topic>Short Report</topic><topic>Streptococcus infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Talman, Sander</creatorcontrib><creatorcontrib>Uzun, Sevim</creatorcontrib><creatorcontrib>Djamin, Remco S</creatorcontrib><creatorcontrib>Baart, Sara J</creatorcontrib><creatorcontrib>Grootenboers, Marco J J H</creatorcontrib><creatorcontrib>Aerts, Joachim</creatorcontrib><creatorcontrib>van der Eerden, Menno</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of chronic obstructive pulmonary disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Talman, Sander</au><au>Uzun, Sevim</au><au>Djamin, Remco S</au><au>Baart, Sara J</au><au>Grootenboers, Marco J J H</au><au>Aerts, Joachim</au><au>van der Eerden, Menno</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease</atitle><jtitle>International journal of chronic obstructive pulmonary disease</jtitle><addtitle>Int J Chron Obstruct Pulmon Dis</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>16</volume><spage>495</spage><epage>498</epage><pages>495-498</pages><issn>1178-2005</issn><issn>1176-9106</issn><eissn>1178-2005</eissn><abstract>Macrolides are effective in reducing the number of exacerbations in COPD patients with the frequent exacerbator phenotype. Our study did not show a persistent effect of azithromycin on exacerbation frequencies after more than one year of usage.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>33688175</pmid><doi>10.2147/COPD.S284397</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-7211-8839</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-2005
ispartof International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.495-498
issn 1178-2005
1176-9106
1178-2005
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_adab09f7e71d43ea9dc613ef50b3f6d8
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central
subjects Antibiotics
Azithromycin
Care and treatment
Chronic obstructive pulmonary disease
copd
Cystic fibrosis
exacerbations
Hospitals
Lung diseases, Obstructive
macrolide
maintenance-therapy
Methicillin
Patient admissions
Pulmonology
Quality of life
Short Report
Streptococcus infections
title Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A48%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Azithromycin%20Maintenance%20Treatment%20in%20Patients%20with%20Frequent%20Exacerbations%20of%20Chronic%20Obstructive%20Pulmonary%20Disease&rft.jtitle=International%20journal%20of%20chronic%20obstructive%20pulmonary%20disease&rft.au=Talman,%20Sander&rft.date=2021-01-01&rft.volume=16&rft.spage=495&rft.epage=498&rft.pages=495-498&rft.issn=1178-2005&rft.eissn=1178-2005&rft_id=info:doi/10.2147/COPD.S284397&rft_dat=%3Cgale_doaj_%3EA654649230%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-adc89a0fb903c6be4127544840aebd1cf5a1004142a9613adfef912a06e4db123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2679382018&rft_id=info:pmid/33688175&rft_galeid=A654649230&rfr_iscdi=true